HPV Vaccine as Adjuvant Therapy in HPV Lesions

dc.contributor.authorSağsöz, Nevin
dc.contributor.authorKhaki, Arash
dc.contributor.authorDavarnia, Ghazaleh
dc.date.accessioned2025-01-21T16:27:43Z
dc.date.available2025-01-21T16:27:43Z
dc.date.issued2024
dc.departmentKırıkkale Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.15296/ijwhr.2024.6019
dc.identifier.endpage151
dc.identifier.issn2330-4456
dc.identifier.issue4
dc.identifier.scopus2-s2.0-85210878423
dc.identifier.scopusqualityQ3
dc.identifier.startpage150
dc.identifier.urihttps://doi.org/10.15296/ijwhr.2024.6019
dc.identifier.urihttps://hdl.handle.net/20.500.12587/23405
dc.identifier.volume12
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherAras Part Medical International Press
dc.relation.ispartofInternational Journal of Women's Health and Reproduction Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectHuman papilloma virus vaccine; adjuvant therapy; antibody response; cancer screening; Editorial; human; immune response; innate immunity; papillomavirus infection; uterine cervix cancer; uterine cervix conization; vaccination
dc.titleHPV Vaccine as Adjuvant Therapy in HPV Lesions
dc.typeEditorial

Dosyalar